Furthermore, clinical studies have indicated that in patients with cirrhosis, circulating butyrate levels have a moderate to strong significant negative correlation with key inflammatory mediators, LPS and IL-6 (LPS: RS = −0.58; IL-6: RS = −0.49; both p < 0.001) (Juanola et al., 2019). This evidence concerns the gene IL6 and Cirrhosis.